Wealth Management

Vendors hold the cards in IT renewals. A new platform aims to change that by arming enterprises with pre-quote intelligence to secure better deals.

A new Bernstein report reveals UHNW families are prioritizing internal resilience and next-gen prep over external market fears, driven by new laws and a deep generational divide.

With a landmark therapy for Sanfilippo Syndrome nearing the FDA, Spruce adds veteran marketing and finance chiefs. A look at the talent behind the transition.

With its new hire, John Gotsch, Fiduciary Trust of New England leverages fresh capital to double down on specialized trust services for the ultra-wealthy.

As AI devalues technical skills, a new framework argues your lived experience is becoming priceless. Discover how to leverage your 'Masterwork Years' for lasting impact.

Dominari Securities' successful $200M fund for the SpaceX IPO isn't just a trade; it's a masterclass in the new mechanics of power and profit on Wall Street.

Lexeo Therapeutics finalizes a pivotal trial for its Friedreich ataxia gene therapy, leveraging a novel trial design and accelerated FDA pathway.

A forum in Xiamen unveils a RMB 9.1 billion push for financial integration, but is it just about business, or a deeper play for Taiwan's future?

While biopharma braces for Medicare price negotiations, Halozyme claims immunity. Is its tech-licensing model the new blueprint for resilience or just a loophole?

After its transformative Plains NGL acquisition, Keyera unveils an aggressive growth plan targeting 16% CAGR, promising a new era of shareholder value.

A new survey shows Asians value independence over inheritance, yet a massive gap between intention and action threatens to derail their plans for self-reliance.

While firms spend billions on tech, a new book argues the biggest data breaches stem from leadership gaps and process failures. Is your boardroom the real front line?

A new FDA-designated device aims to filter a deadly protein from the blood of sepsis patients. Can this novel approach finally conquer a global health crisis?

AM Best's 'a-' rating on Ameriprise's new notes isn't just a grade; it's a testament to strategic foresight and a beacon for investors.

As economic jitters push investors toward tangible assets, a new ranking names the top Gold IRA firms. But is this modern gold rush a savvy move or a costly trap?

Swan Bitcoin's RBX lets investors trade ETF shares for real Bitcoin. Is this the next evolution of crypto ownership or a challenge to Wall Street's new products?

Dynasty Financial Partners acquires consulting firm Optima Group, betting that a fully integrated platform of tech, capital, and strategy is the future of RIA support.

Wealth manager Noah Holdings rewards shareholders with a massive dividend, representing 100% of profits, signaling deep confidence amid a global expansion.

New data shows Canadians are fixated on inflation, yet their demand for values-aligned investing is growing. Can the financial industry deliver on both?

A BMO survey reveals a stark new reality: financial stability is trumping romance, trapping some in marriage and turning partnership into a fiscal strategy.